• Front Matter R1-R20

• Summary 1-20

• 1 Introduction 21-44

• 2 Governance and Conduct of Studies 45-72

• 3 Evidence Base and Methods for Studying Health Effects 73-148

• 4 Methods for Investigating Addictive Potential 149-190

• 5 Methods for Studying Risk Perception and Risk Communication 191-220

• 6 Decision Making and Oversight of MRTP Studies: Findings and Recommendations 221-246

• Appendix A: Section 911 of the Family Smoking Prevention and Tobacco Control Act of 2009 247-256

• Appendix B: Chapters 1 and 2 from *Evaluation of Biomarkers andSurrogate Endpoints in Chronic Disease* 257-258

• [Appendix B] 1 Introduction 259-274

• [Appendix B] 2 Review: Evaluating and Regulating Biomarker Use 275-338

• Appendix C: Committee Biographies 339-346

• Appendix D: Meeting Agendas 347-350

" 6 Decision Making and Oversight of MRTP Studies: Findings and Recommendations ." Scientific Standards for Studies on Modified Risk Tobacco Products . Washington, DC: The National Academies Press, 2012 .

Please select a format: